• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNA 修复蛋白 MSH2、MLH1 和 MGMT 在活动舌鳞癌中的表达:与临床病理参数和患者生存的关系。

Expression of DNA repair proteins, MSH2, MLH1 and MGMT in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival.

机构信息

Department of Pathology, Head and Neck Surgery, Institut Curie, Paris, France.

出版信息

J Oral Pathol Med. 2011 Mar;40(3):218-26. doi: 10.1111/j.1600-0714.2010.00945.x. Epub 2010 Oct 1.

DOI:10.1111/j.1600-0714.2010.00945.x
PMID:21029181
Abstract

BACKGROUND

DNA repair is a major defense mechanism, which contributes to the maintenance of genetic sequence, minimizing cell death, mutation rates, replication errors, DNA damage persistence and genomic instability. Alterations of proteins participating in DNA repair mechanisms have been associated with several aspects of cancer biology. The present study aimed to evaluate the clinical significance of DNA repair proteins, MSH2, MLH1 and MGMT in mobile tongue squamous cell carcinoma (SCC).

METHODS

MSH2, MLH1 and MGMT protein expression was assessed immunohistochemically on 49 mobile tongue SCC tissue samples and was analyzed in relation with clinicopathological characteristics, overall and disease-free patients' survival.

RESULTS

MSH2 expression was significantly associated with depth of invasion (P=0.0335), tumor shape (P=0.0396) and muscular invasion (P=0.0098). MLH1 expression was significantly associated with lymph node metastases (P=0.0484) and borderline with perineural invasion (P=0.0699). MGMT expression was significantly associated with depth of invasion (P=0.0472), tumor shape (P=0.0187), perineural invasion (P=0.0115) and lymph node metastases (P=0.0032) and borderline with vascular invasion (P=0.0755). MSH2 expression was significantly associated with disease-free patients' survival in univariate analysis (P=0.0441), being also identified as an independent prognostic factor in multivariate analysis (P=0.0451).

CONCLUSIONS

The present study supported evidence for possible implication of MSH2, MLH1 and MGMT proteins in the formation and progression of mobile tongue SCC.

摘要

背景

DNA 修复是一种主要的防御机制,有助于维持遗传序列,最大限度地减少细胞死亡、突变率、复制错误、DNA 损伤持续存在和基因组不稳定性。参与 DNA 修复机制的蛋白质的改变与癌症生物学的几个方面有关。本研究旨在评估 DNA 修复蛋白 MSH2、MLH1 和 MGMT 在移动性舌鳞状细胞癌(SCC)中的临床意义。

方法

在 49 例移动性舌 SCC 组织样本中,通过免疫组织化学评估 MSH2、MLH1 和 MGMT 蛋白的表达,并分析其与临床病理特征、总生存率和无病生存率的关系。

结果

MSH2 表达与浸润深度(P=0.0335)、肿瘤形状(P=0.0396)和肌肉浸润(P=0.0098)显著相关。MLH1 表达与淋巴结转移(P=0.0484)显著相关,与神经周围侵犯(P=0.0699)呈临界相关。MGMT 表达与浸润深度(P=0.0472)、肿瘤形状(P=0.0187)、神经周围侵犯(P=0.0115)和淋巴结转移(P=0.0032)显著相关,与血管侵犯(P=0.0755)呈临界相关。MSH2 表达在单因素分析中与无病生存率显著相关(P=0.0441),在多因素分析中也被确定为独立的预后因素(P=0.0451)。

结论

本研究支持 MSH2、MLH1 和 MGMT 蛋白可能参与移动性舌 SCC 的形成和进展的证据。

相似文献

1
Expression of DNA repair proteins, MSH2, MLH1 and MGMT in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival.DNA 修复蛋白 MSH2、MLH1 和 MGMT 在活动舌鳞癌中的表达:与临床病理参数和患者生存的关系。
J Oral Pathol Med. 2011 Mar;40(3):218-26. doi: 10.1111/j.1600-0714.2010.00945.x. Epub 2010 Oct 1.
2
Expression of DNA repair proteins MSH2, MLH1 and MGMT in human benign and malignant thyroid lesions: an immunohistochemical study.DNA 修复蛋白 MSH2、MLH1 和 MGMT 在人甲状腺良恶性病变中的表达:免疫组化研究。
Med Sci Monit. 2011 Feb 25;17(3):BR81-90. doi: 10.12659/msm.881444.
3
Histone deacetylase-1 and -2 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.移动性舌鳞癌中组蛋白去乙酰化酶-1 和 -2 的表达:与临床病理参数和患者生存的关系。
J Oral Pathol Med. 2011 Oct;40(9):706-14. doi: 10.1111/j.1600-0714.2011.01031.x. Epub 2011 Apr 2.
4
Prognostic significance of DNA repair proteins MLH1, MSH2 and MGMT expression in non-small-cell lung cancer and precursor lesions.DNA修复蛋白MLH1、MSH2和MGMT表达在非小细胞肺癌及癌前病变中的预后意义
Histopathology. 2008 Apr;52(5):613-22. doi: 10.1111/j.1365-2559.2008.02999.x.
5
Expression of DNA mismatch repair proteins MLH1, MSH2, and MSH6 in recurrent glioblastoma.DNA错配修复蛋白MLH1、MSH2和MSH6在复发性胶质母细胞瘤中的表达
Neurol Res. 2015 Feb;37(2):95-105. doi: 10.1179/1743132814Y.0000000409. Epub 2014 Jul 4.
6
Predictive value of MGMT, hMLH1, hMSH2 and BRCA1 protein expression for pathological complete response to neoadjuvant chemotherapy in basal-like breast cancer patients.MGMT、hMLH1、hMSH2 和 BRCA1 蛋白表达对基底样乳腺癌患者新辅助化疗病理完全缓解的预测价值。
Cancer Chemother Pharmacol. 2012 Apr;69(4):923-30. doi: 10.1007/s00280-011-1777-7. Epub 2011 Nov 15.
7
Tissue expression of MLH1, PMS2, MSH2, and MSH6 proteins and prognostic value of microsatellite instability in Wilms tumor: experience of 45 cases.WT1中MLH1、PMS2、MSH2和MSH6蛋白的组织表达及微卫星不稳定性的预后价值:45例经验
Pediatr Hematol Oncol. 2013 May;30(4):273-84. doi: 10.3109/08880018.2013.780274.
8
Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in esophageal squamous cell carcinoma.hMLH1和hMSH2表达缺失是食管鳞状细胞癌的不良预后因素。
J Surg Oncol. 2005 Nov 1;92(2):109-15. doi: 10.1002/jso.20332.
9
Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients.喉鳞状细胞癌中CDKN2A、MGMT、MLH1和DAPK基因的启动子高甲基化及其与患者临床特征的关联。
Head Neck. 2014 Aug;36(8):1103-8. doi: 10.1002/hed.23413. Epub 2013 Oct 7.
10
Reduced expression of mutS homolog 2 and mutL homolog 1 affects overall survival in laryngeal squamous cell carcinoma patients: Investigation into a potential cause.错配修复基因 2 与 mutL 同源物 1 表达降低影响喉鳞癌患者的总生存:潜在病因的探讨。
Oncol Rep. 2013 Sep;30(3):1371-9. doi: 10.3892/or.2013.2559. Epub 2013 Jun 20.

引用本文的文献

1
Clinicopathological and Immunohistochemical Risk Predictors for Ameloblastoma Recurrence.成釉细胞瘤复发的临床病理及免疫组化风险预测指标
Head Neck Pathol. 2025 Feb 17;19(1):22. doi: 10.1007/s12105-024-01743-1.
2
Screening for Biomarkers for Progression from Oral Leukoplakia to Oral Squamous Cell Carcinoma and Evaluation of Diagnostic Efficacy by Multiple Machine Learning Algorithms.口腔白斑向口腔鳞状细胞癌进展的生物标志物筛查及多种机器学习算法的诊断效能评估
Cancers (Basel). 2022 Nov 25;14(23):5808. doi: 10.3390/cancers14235808.
3
DNA Damage Response during Replication Correlates with CIN70 Score and Determines Survival in HNSCC Patients.
复制过程中的DNA损伤反应与CIN70评分相关,并决定头颈部鳞状细胞癌患者的生存情况。
Cancers (Basel). 2021 Mar 10;13(6):1194. doi: 10.3390/cancers13061194.
4
The Mismatch Repair System (MMR) in Head and Neck Carcinogenesis and Its Role in Modulating the Response to Immunotherapy: A Critical Review.头颈部肿瘤发生中的错配修复系统(MMR)及其在调节免疫治疗反应中的作用:一项批判性综述
Cancers (Basel). 2020 Oct 16;12(10):3006. doi: 10.3390/cancers12103006.
5
Human MutL homolog 1 immunoexpression in oral leukoplakia and oral squamous cell carcinoma: A prospective study in Indian population.人MutL同源蛋白1在口腔白斑和口腔鳞状细胞癌中的免疫表达:印度人群的前瞻性研究。
J Oral Maxillofac Pathol. 2016 Sep-Dec;20(3):453-461. doi: 10.4103/0973-029X.190948.
6
Integrative Genomics and Transcriptomics Analysis Reveals Potential Mechanisms for Favorable Prognosis of Patients with HPV-Positive Head and Neck Carcinomas.整合基因组学和转录组学分析揭示HPV阳性头颈癌患者预后良好的潜在机制。
Sci Rep. 2016 Apr 25;6:24927. doi: 10.1038/srep24927.
7
Genome stability pathways in head and neck cancers.头颈癌中的基因组稳定性通路。
Int J Genomics. 2013;2013:464720. doi: 10.1155/2013/464720. Epub 2013 Nov 4.
8
Low expression of MSH2 DNA repair protein is associated with poor prognosis in head and neck squamous cell carcinoma.MSH2 错配修复蛋白低表达与头颈部鳞状细胞癌预后不良相关。
J Appl Oral Sci. 2013 Sep-Oct;21(5):416-21. doi: 10.1590/1679-775720130206.
9
O(6)-methylguanine-DNA methyltransferase in equine sarcoids: molecular and epigenetic analysis.马肉瘤中的 O(6)-甲基鸟嘌呤-DNA 甲基转移酶:分子和表观遗传分析。
BMC Vet Res. 2012 Nov 10;8:218. doi: 10.1186/1746-6148-8-218.
10
FAK and Src expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.FAK 和Src 在移动性舌鳞癌中的表达:与临床病理参数和患者生存的关系。
J Cancer Res Clin Oncol. 2012 Aug;138(8):1369-77. doi: 10.1007/s00432-012-1215-1. Epub 2012 Apr 10.